<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>rivastigmine</title><link>http://www.unboundmedicine.com/medline/ebm/research/rivastigmine</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Safety and Tolerability of Donepezil, Rivastigmine and Galantamine for Patients with Alzheimer's Disease: Systematic Review of the 'Real-World' Evidence.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19893314/full_citation/Safety_and_Tolerability_of_Donepezil_Rivastigmine_and_Galantamine_for_Patients_with_Alzheimer's_Disease:_Systematic_Review_of_the_'Real_World'_Evidence_</link><description>Lockhart IA, Mitchell SA, Kelly S <br/><span class="title">Safety and Tolerability of Donepezil, Rivastigmine and Galantamine for Patients with Alzheimer's Disease: Systematic Review of the 'Real-World' Evidence. [JOURNAL ARTICLE]</span><br/><span class="source" title="Dementia and geriatric cognitive disorders">Dement Geriatr Cogn Disord 2009 Nov 6; 28(5):389-403.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19893314/abstract/Safety_and_Tolerability_of_Donepezil_Rivastigmine_and_Galantamine_for_Patients_with_Alzheimer's_Disease:_Systematic_Review_of_the_'Real_World'_Evidence_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19893314/full_citation/Safety_and_Tolerability_of_Donepezil_Rivastigmine_and_Galantamine_for_Patients_with_Alzheimer's_Disease:_Systematic_Review_of_the_'Real_World'_Evidence_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19893314/Safety_and_Tolerability_of_Donepezil_Rivastigmine_and_Galantamine_for_Patients_with_Alzheimer's_Disease:_Systematic_Review_of_the_'Real_World'_Evidence_">Find Related Articles</a> </description></item><item><title>Hepatitis with cholestasis caused by rivastigmine transdermal patch.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19888250/full_citation/Hepatitis_with_cholestasis_caused_by_rivastigmine_transdermal_patch_</link><description>Mumoli N, Carmignani G, Luschi R, et al. <br/><span class="title">Hepatitis with cholestasis caused by rivastigmine transdermal patch. [Letter]</span><br/><span class="source" title="The American journal of gastroenterology">Am J Gastroenterol 2009 Nov; 104(11):2859-60.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19888250/full_citation/Hepatitis_with_cholestasis_caused_by_rivastigmine_transdermal_patch_">Full Citation</a></description></item><item><title>Effects of Cholinesterase Inhibitors on the Activities and Protein Levels of Cholinesterases in the Cerebrospinal Fluid of Patients with Alzheimer's Disease: A Review of Recent Clinical Studies.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19860725/full_citation/Effects_of_Cholinesterase_Inhibitors_on_the_Activities_and_Protein_Levels_of_Cholinesterases_in_the_Cerebrospinal_Fluid_of_Patients_with_Alzheimer's_Disease:_A_Review_of_Recent_Clinical_Studies_</link><description>Darreh-Shori T, Soininen H <br/><span class="title">Effects of Cholinesterase Inhibitors on the Activities and Protein Levels of Cholinesterases in the Cerebrospinal Fluid of Patients with Alzheimer's Disease: A Review of Recent Clinical Studies. [JOURNAL ARTICLE]</span><br/><span class="source" title="Current Alzheimer research">Curr Alzheimer Res 2009 Sep 28.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19860725/abstract/Effects_of_Cholinesterase_Inhibitors_on_the_Activities_and_Protein_Levels_of_Cholinesterases_in_the_Cerebrospinal_Fluid_of_Patients_with_Alzheimer's_Disease:_A_Review_of_Recent_Clinical_Studies_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19860725/full_citation/Effects_of_Cholinesterase_Inhibitors_on_the_Activities_and_Protein_Levels_of_Cholinesterases_in_the_Cerebrospinal_Fluid_of_Patients_with_Alzheimer's_Disease:_A_Review_of_Recent_Clinical_Studies_">Full Citation</a></description></item><item><title>Review: rivastigmine reduces rate of cognitive decline and improves performance in mild to moderate Alzheimer's.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19854775/full_citation/Review:_rivastigmine_reduces_rate_of_cognitive_decline_and_improves_performance_in_mild_to_moderate_Alzheimer's_</link><description>Carlos Machado J <br/><span class="title">Review: rivastigmine reduces rate of cognitive decline and improves performance in mild to moderate Alzheimer's. [Journal Article]</span><br/><span class="source" title="Evidence-based mental health">Evid Based Ment Health 2009 Nov; 12(4):113.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19854775/full_citation/Review:_rivastigmine_reduces_rate_of_cognitive_decline_and_improves_performance_in_mild_to_moderate_Alzheimer's_">Full Citation</a> | <a href="http://ebmh.bmj.com/cgi/pmidlookup%3fview=long%26amp;pmid=19854775">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19854775/Review:_rivastigmine_reduces_rate_of_cognitive_decline_and_improves_performance_in_mild_to_moderate_Alzheimer's_">Find Related Articles</a> </description></item><item><title>Safety/Tolerability and efficacy of rivastigmine in taiwanese patients with Alzheimer's disease: a prospective post-marketing surveillance study.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19813776/full_citation/Safety/Tolerability_and_efficacy_of_rivastigmine_in_taiwanese_patients_with_Alzheimer's_disease:_a_prospective_post_marketing_surveillance_study_</link><description>Chiu PY, Dai DE, Hsu HP, et al. <br/><span class="title">Safety/Tolerability and efficacy of rivastigmine in taiwanese patients with Alzheimer's disease: a prospective post-marketing surveillance study. [Journal Article]</span><br/><span class="source" title="Clinical drug investigation">Clin Drug Investig 2009; 29(11):729-38.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19813776/abstract/Safety/Tolerability_and_efficacy_of_rivastigmine_in_taiwanese_patients_with_Alzheimer's_disease:_a_prospective_post_marketing_surveillance_study_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19813776/full_citation/Safety/Tolerability_and_efficacy_of_rivastigmine_in_taiwanese_patients_with_Alzheimer's_disease:_a_prospective_post_marketing_surveillance_study_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19813776/Safety/Tolerability_and_efficacy_of_rivastigmine_in_taiwanese_patients_with_Alzheimer's_disease:_a_prospective_post_marketing_surveillance_study_">Find Related Articles</a> </description></item><item><title>Neurometabolic correlations of donepezil and rivastigmine in dementia patients: a different neuroprotective effect.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19776323/full_citation/Neurometabolic_correlations_of_donepezil_and_rivastigmine_in_dementia_patients:_a_different_neuroprotective_effect_</link><description>Parlayan E, Yulug B, Bakar M, et al. <br/><span class="title">Neurometabolic correlations of donepezil and rivastigmine in dementia patients: a different neuroprotective effect. [Letter]</span><br/><span class="source" title="The Journal of neuropsychiatry and clinical neurosciences">J Neuropsychiatry Clin Neurosci 2009; 21(3):348-50.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19776323/full_citation/Neurometabolic_correlations_of_donepezil_and_rivastigmine_in_dementia_patients:_a_different_neuroprotective_effect_">Full Citation</a> | <a href="http://neuro.psychiatryonline.org/cgi/pmidlookup%3fview=long%26amp;pmid=19776323">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19776323/Neurometabolic_correlations_of_donepezil_and_rivastigmine_in_dementia_patients:_a_different_neuroprotective_effect_">Find Related Articles</a> </description></item><item><title>Peripheral cholinoceptor antagonist anisodamine counteracts cholinergic adverse effects and facilitates cognitive amelioration of rivastigmine.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19756370/full_citation/Peripheral_cholinoceptor_antagonist_anisodamine_counteracts_cholinergic_adverse_effects_and_facilitates_cognitive_amelioration_of_rivastigmine_</link><description>Zhang WW, Xu ZP, Cui YY, et al. <br/><span class="title">Peripheral cholinoceptor antagonist anisodamine counteracts cholinergic adverse effects and facilitates cognitive amelioration of rivastigmine. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of neural transmission (Vienna, Austria : 1996)">J Neural Transm 2009 Sep 12.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19756370/abstract/Peripheral_cholinoceptor_antagonist_anisodamine_counteracts_cholinergic_adverse_effects_and_facilitates_cognitive_amelioration_of_rivastigmine_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19756370/full_citation/Peripheral_cholinoceptor_antagonist_anisodamine_counteracts_cholinergic_adverse_effects_and_facilitates_cognitive_amelioration_of_rivastigmine_">Full Citation</a></description></item><item><title>Use of pralidoxime without atropine in rivastigmine (carbamate) toxicity.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19755437/full_citation/Use_of_pralidoxime_without_atropine_in_rivastigmine__carbamate__toxicity_</link><description>Hoffman RS, Manini AF, Russell-Haders AL, et al. <br/><span class="title">Use of pralidoxime without atropine in rivastigmine (carbamate) toxicity. [JOURNAL ARTICLE]</span><br/><span class="source" title="Human &amp; experimental toxicology">Hum Exp Toxicol 2009 Sep 15.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19755437/abstract/Use_of_pralidoxime_without_atropine_in_rivastigmine__carbamate__toxicity_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19755437/full_citation/Use_of_pralidoxime_without_atropine_in_rivastigmine__carbamate__toxicity_">Full Citation</a></description></item><item><title>Effectiveness of donepezil, rivastigmine and ({+/-})huperzine A in counteracting the acute toxicity of organophosphorus nerve agents: Comparison with galantamine.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19741148/full_citation/Effectiveness_of_donepezil_rivastigmine_and__{+/_}_huperzine_A_in_counteracting_the_acute_toxicity_of_organophosphorus_nerve_agents:_Comparison_with_galantamine_</link><description>Aracava Y, Pereira E, Akkerman M, et al. <br/><span class="title">Effectiveness of donepezil, rivastigmine and ({+/-})huperzine A in counteracting the acute toxicity of organophosphorus nerve agents: Comparison with galantamine. [JOURNAL ARTICLE]</span><br/><span class="source" title="The Journal of pharmacology and experimental therapeutics">J Pharmacol Exp Ther 2009 Sep 9.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19741148/abstract/Effectiveness_of_donepezil_rivastigmine_and__{+/_}_huperzine_A_in_counteracting_the_acute_toxicity_of_organophosphorus_nerve_agents:_Comparison_with_galantamine_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19741148/full_citation/Effectiveness_of_donepezil_rivastigmine_and__{+/_}_huperzine_A_in_counteracting_the_acute_toxicity_of_organophosphorus_nerve_agents:_Comparison_with_galantamine_">Full Citation</a> | <a href="http://jpet.aspetjournals.org/cgi/pmidlookup%3fview=long%26amp;pmid=19741148">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19741148/Effectiveness_of_donepezil_rivastigmine_and__{+/_}_huperzine_A_in_counteracting_the_acute_toxicity_of_organophosphorus_nerve_agents:_Comparison_with_galantamine_">Find Related Articles</a> </description></item><item><title>Current Treatments of Alzheimer Disease: Are Main Caregivers Satisfied with the Drug Treatments Received by Their Patients?</title><link>http://www.unboundmedicine.com/medline/ebm/record/19738386/full_citation/Current_Treatments_of_Alzheimer_Disease:_Are_Main_Caregivers_Satisfied_with_the_Drug_Treatments_Received_by_Their_Patients</link><description>Sevilla C, Jiménez Caballero PE, Alfonso V, et al. <br/><span class="title">Current Treatments of Alzheimer Disease: Are Main Caregivers Satisfied with the Drug Treatments Received by Their Patients? [JOURNAL ARTICLE]</span><br/><span class="source" title="Dementia and geriatric cognitive disorders">Dement Geriatr Cogn Disord 2009 Sep 9; 28(3):196-205.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19738386/abstract/Current_Treatments_of_Alzheimer_Disease:_Are_Main_Caregivers_Satisfied_with_the_Drug_Treatments_Received_by_Their_Patients">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19738386/full_citation/Current_Treatments_of_Alzheimer_Disease:_Are_Main_Caregivers_Satisfied_with_the_Drug_Treatments_Received_by_Their_Patients">Full Citation</a></description></item></channel></rss>